Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise effect on Unfractionated Heparin PK/PD
NCT06174961Phase 4Completed
- Start
- Sep 2023
- Primary completion
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of heparin in blood coagulation disorder (4 arms). Primary endpoint: Activated Partial Thromboplastin Time. Started Sep 2023; status: completed.
02
Drugs
heparin
03
Conditions
blood coagulation disorder
Beyond the preview
Go deeper on NCT06174961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174961.